228 related articles for article (PubMed ID: 6305653)
1. Molecular forms of beta-N-acetylhexosaminidase in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and patients with Tay-Sachs disease.
Salvayre R; Maret A; Negre A; Lenoir G; Vuillaume M; Icart J; Didier J; Douste-Blazy L
Eur J Biochem; 1983 Jul; 133(3):627-33. PubMed ID: 6305653
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus transformed lymphoid cell lines as a new model system in culture for the study of GM2-gangliosidoses: Tay-Sachs and Sandhoff diseases.
Maret A; Salvayre R; Negre A; Bes JC; Douste-Blazy L
Biol Cell; 1985; 53(3):293-6. PubMed ID: 2990625
[TBL] [Abstract][Full Text] [Related]
3. A new form of residual hexosaminidase activity in infantile Tay Sachs disease fibroblasts.
Hechtman P; Khoo K; Isaacs C
Clin Genet; 1983 Sep; 24(3):206-15. PubMed ID: 6226462
[TBL] [Abstract][Full Text] [Related]
4. Validity of lymphoid cell line for enzymatic studies of GM2-gangliosidosis variant 0 (Sandhoff disease).
Maret A; Salvayre R; Radon J; Hardy M; Vuillaume M; Lenoir G; Douste-Blazy L
Enzyme; 1985; 34(1):48-56. PubMed ID: 3002784
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
Bayleran J; Hechtman P; Saray W
Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
[TBL] [Abstract][Full Text] [Related]
6. Hereditary heat-labile hexosaminidase B: its implication for recognizing Tay-Sachs genotypes.
Navon R; Nutman J; Kopel R; Gaber L; Gadoth N; Goldman B; Nitzan M
Am J Hum Genet; 1981 Nov; 33(6):907-15. PubMed ID: 6459736
[TBL] [Abstract][Full Text] [Related]
7. Hereditary heat-labile hexosaminidase B: a variant whose homozygotes synthesize a functional HEX A.
Navon R; Kopel R; Nutman J; Frisch A; Conzelmann E; Sandhoff K; Adam A
Am J Hum Genet; 1985 Jan; 37(1):138-46. PubMed ID: 3156493
[TBL] [Abstract][Full Text] [Related]
8. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
Hechtman P; Boulay B; Bayleran J; Andermann E
Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
[TBL] [Abstract][Full Text] [Related]
9. Detection of Tay-Sachs disease carriers among individuals with thermolabile hexosaminidase B.
Peleg L; Goldman B
Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):65-9. PubMed ID: 8003579
[TBL] [Abstract][Full Text] [Related]
10. beta-hexosaminidase in cultured normal and mutant human fibroblasts: an immunohistochemical and biochemical investigation.
Elsafi ME; Elbashir MI; Hultberg B; Isaksson A; Hägerstrand I; Stenram U
Scand J Clin Lab Invest; 1991 Dec; 51(8):711-4. PubMed ID: 1839650
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.
Mark BL; Mahuran DJ; Cherney MM; Zhao D; Knapp S; James MN
J Mol Biol; 2003 Apr; 327(5):1093-109. PubMed ID: 12662933
[TBL] [Abstract][Full Text] [Related]
12. Prenatal diagnosis of Tay-Sachs disease. Reflectometry of hexosaminidase A, B, and C/S bands on zymograms.
Kustermann-Kuhn B; Harzer K
Hum Genet; 1983; 65(2):172-5. PubMed ID: 6228513
[TBL] [Abstract][Full Text] [Related]
13. Presence of an atypical thermolabile species of beta-hexosaminidase B in metastatic-tumour tissue of human liver.
Alhadeff JA; Holzinger RT
Biochem J; 1982 Jan; 201(1):95-9. PubMed ID: 6211170
[TBL] [Abstract][Full Text] [Related]
14. Unusual thermolability properties of leukocyte beta-hexosaminidase: implications in screening for carriers of Tay-Sachs disease.
Prence EM; Natowicz MR; Zalewski I
Clin Chem; 1993 Sep; 39(9):1811-4. PubMed ID: 8375052
[TBL] [Abstract][Full Text] [Related]
15. Unusual thermolability properties of beta-hexosaminidase: studies of enzyme from cultured cells and clinical implications.
Prence EM; Zalewski I; Natowicz MR
Am J Med Genet; 1996 Nov; 65(4):320-4. PubMed ID: 8923943
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytes.
Inui K; Wenger DA
Clin Genet; 1984 Oct; 26(4):318-21. PubMed ID: 6238730
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay and heat denaturation enzyme assay for the detection of Tay-sachs heterozygotes during pregnancy.
Nguyen C; Gold RJ; Mahuran D; Lowden JA
Clin Chim Acta; 1981 Jun; 113(1):13-25. PubMed ID: 6453673
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of Tay-Sachs disease by estimation of beta-N-acetylhexosaminidase activity using a radiolabeled hyaluronic acid-derived trisaccharide substrate.
Yutaka T; Kato T; Midorikawa M; Doke M; Okada S; Yabuuchi H
Clin Chim Acta; 1984 Feb; 137(2):159-68. PubMed ID: 6231138
[TBL] [Abstract][Full Text] [Related]
19. Tay-Sachs disease: one-step assay of beta-N-acetylhexosaminidase in serum with a sulphated chromogenic substrate.
Fuchs W; Navon R; Kaback MM; Kresse H
Clin Chim Acta; 1983 Oct; 133(3):253-61. PubMed ID: 6226458
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and carrier detection of Tay-Sachs disease: direct determination of hexosaminidase A using 4-methylumbelliferyl derivatives of beta-N-acetylglucosamine-6-sulfate and beta-N-acetylgalactosamine-6-sulfate.
Ben-Yoseph Y; Reid JE; Shapiro B; Nadler HL
Am J Hum Genet; 1985 Jul; 37(4):733-40. PubMed ID: 9556661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
